home / stock / bway / bway news


BWAY News and Press, BrainsWay Ltd. From 11/03/21

Stock Information

Company Name: BrainsWay Ltd.
Stock Symbol: BWAY
Market: NYSE
Website: brainsway.com

Menu

BWAY BWAY Quote BWAY Short BWAY News BWAY Articles BWAY Message Board
Get BWAY Alerts

News, Short Squeeze, Breakout and More Instantly...

BWAY - BrainsWay to Report Third Quarter 2021 Financial Results on November 17, 2021

BURLINGTON, Mass. and JERUSALEM, Nov. 03, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that it wi...

BWAY - BrainsWay Announces Prominent Addition to Scientific Advisory Board

BURLINGTON, Mass. and JERUSALEM, Oct. 12, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay" or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced the addit...

BWAY - BrainsWay Announces Data Published in World Psychiatry on Deep Transcranial Magnetic Stimulation (Deep TMS(TM)) for Smoking Addiction

Evidence Supports Use of Deep TMS as a Safe and Effective Treatment for Smoking Addiction BURLINGTON, Mass. and JERUSALEM, Sept. 30, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay'' or the “Company”), a global leader in a...

BWAY - Brainsway (BWAY ) Investor Presentation - Slideshow

The following slide deck was published by BrainsWay Ltd. in conjunction with this event. For further details see: Brainsway (BWAY ) Investor Presentation - Slideshow

BWAY - BrainsWay to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

BURLINGTON, Mass. and JERUSALEM, Aug. 30, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that Chris...

BWAY - FDA Clears BrainsWay Deep TMS(TM) System for Decreasing Anxiety Symptoms in Depressed Patients

BURLINGTON, Mass. and JERUSALEM, Aug. 18, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that it ha...

BWAY - BrainsWay Hosting Key Opinion Leader Webinar on its Deep TMS(TM) Therapy for Treating Mental Health Disorders

BURLINGTON, Mass. and JERUSALEM, Aug. 17, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that it wi...

BWAY - BrainsWay Ltd.'s (BWAY) CEO Christopher von Jako on Q2 2021 Results - Earnings Call Transcript

BrainsWay Ltd. (BWAY) Q2 2021 Earnings Conference Call August 11, 2021, 8:30 AM ET Company Participants Brian Ritchie - LifeSci Advisors, IR Christopher von Jako - President and CEO Scott Areglado - Chief Financial Officer Conference Call Participants Jayson Bedford - Raymond James Steven Lic...

BWAY - BrainsWay Ltd. 2021 Q2 - Results - Earnings Call Presentation

The following slide deck was published by BrainsWay Ltd. in conjunction with their 2021 Q2 earnings call. For further details see: BrainsWay Ltd. 2021 Q2 - Results - Earnings Call Presentation

BWAY - BrainsWay Reports Second Quarter 2021 Financial Results and Operational Highlights

Strong Revenue Growth of 45% Year-over-Year in Q2 2021 Gained Meaningful Traction in Reimbursement for Deep TMS™ in both OCD and Depression Conference Call to be held Today at 8:30 AM ET BURLINGTON, Mass. and JERUSALEM, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Brai...

Previous 10 Next 10